Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures

References

• Adle‐Biassette H, Levy Y, Colombel M, Poron F, Natchev S, Keohane C, Gray F. Neuronal apoptosis in HIV infection in adults. Neuropath Appl Neurobio 1995; 21: 218–227
   PubMed Web of Science ®Google Scholar
• Arya S K, Guo C, Josephs S F, Wong‐Staal F. Transactivator gene of human T‐lymphotrophic virus type III (HTLV.‐III). Science 1985; 229: 69–73
   PubMed Web of Science ®Google Scholar
• Bernton E, Bryant H, Decoster M, Orenstein J M, Ribas J, Meltzer M S, Gendelman H E. No direct neuronotoxicity by HIV‐1 virions or culture fluids from HIV‐1 infected T cells or monocytes. AIDS Res Hum Retroviruses 1992; 8: 495–503
   PubMed Web of Science ®Google Scholar
• Buonaguro L, Barillari G, Chang H K, Bohan C A, Kao V, Morgan R, Gallo R C, Ensoli B. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J Virol 1992; 66: 7159–7167
   PubMed Web of Science ®Google Scholar
• Conant K, Ma M, Nath A, Major E O. Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF‐kB binding and protein kinase C activity in primary human astrocytes. J Virol 1996; 70: 1384–1389
   PubMed Web of Science ®Google Scholar
• Ehret A, Westendorp M O, Herr I, Debatin K ‐M, Heeney J L, Frank R, Krammer P H. Resistance of chimpanzee T cells to human immunodeficiency virus type 1 Tat‐enhanced oxidative stress and apoptosis. J Virol 1996; 70: 6502–6507
   PubMed Web of Science ®Google Scholar
• Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan R, Wingfield P, Gallo R. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 1992; 67: 277–287
   Google Scholar
• Epstein L G, Gendelman H E. Human immunodeficiency virus type 1 infection of the nervous system: Pathogenetic mechanisms. Ann Neurol 1993; 33: 429–436
   PubMed Web of Science ®Google Scholar
• Frankel A D, Pabo C O. Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 1988; 55: 1189–1193
   PubMed Web of Science ®Google Scholar
• Gelbard H A, James H J, Sharer L R, Perry S W, Saito Y, Kazee A, Blumberg B M, Epstein L G. Apoptotic neurons in brains from paediatric patients with HIV‐1 encephalitis and progressive encephalopathy. Neuropath Appl Neurobio 1995; 21: 208–217
   PubMed Web of Science ®Google Scholar
• Gelbard H A, Nottet H S L, Swindells S, Jett M, Dzenko K, Genis P, White R, Wang L, Choi Y, Zhang D, Lipton S A, Tourtellotte W W, Epstein L G, Gendelman H E. Platelet‐activating factor: a candidate human immunodeficiency virus type 1‐induced neurotoxin. J Virol 1994; 68: 4628–4635
   PubMed Web of Science ®Google Scholar
• Genis P, Jett M, Bernton E W, Gelbard H A, Dzenko K, Keane R, Resnick L, Volsky D J, Epstein L G, Gendelman H E. Cytokines and arachidonic acid metabolites produced during HIV‐infected macrophage‐astroglial interactions: Implications for the neuropathogenesis of HIV disease. J Exp Med 1992; 176: 1703–1718
   Google Scholar
• Giulian D, Vaca K, Noonan C A. Secretion of neurotoxins by mononuclear phagocytes infected with HIV‐1. Science 1990; 250: 1593–1596
   PubMed Web of Science ®Google Scholar
• Hauber J, Perkins A, Heimer E, Cullen B. Trans‐activation of human immunodeficiency virus gene expression is mediated by nuclear events. Proc Natl Acad Sci USA 1987; 84: 6364–6368
   PubMedGoogle Scholar
• Hayat M A. Fixation for electron microscopy. Academic Press, New York, New York 1981
   Google Scholar
• Hayman M, Arbuthnott G, Harkiss G, Brace H, Filippi P, Philippon V, Thomson D, Vigne R, Wright A. Neurotoxicity of peptide analogues of the transactivating protein tat from maedi‐visna virus and human immunodeficiency virus. Neuroscience 1993; 53: 1–6
   PubMed Web of Science ®Google Scholar
• Helland D, Welles J, Caputo A, Haseltine W. Transcellular transactivation by the human immunodeficiency virus type 1 Tat protein. J Virol 1991; 65: 4547–4549
   Google Scholar
• Herrmann C H, Rice A P. Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. Virology 1993; 197: 601–608
   PubMed Web of Science ®Google Scholar
• Li C J, Friedman D J, Wang C, Metelev V, Pardee A B. Induction of apoptosis in uninfected lymphocytes by HIV‐1 Tat protein. Science 1995; 268: 429–431
   PubMed Web of Science ®Google Scholar
• Magnuson D S K, Knudsen B E, Geiger J D, Brownstone R M, Nath A. Human immunodeficiency virus type 1 Tat activates non‐N‐methyl‐D‐aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol 1995; 37: 373–380
   PubMed Web of Science ®Google Scholar
• Marcuzzi A, Weinberger J, Weinberger O K. Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in co‐cultured lymphocytes. J Virol 1992a; 66: 4228–4232
   Google Scholar
• Marcuzzi A, Weinberger J, Weinberger O K. Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in T lymphocytes requires CD4‐gp120 binding. J Virol 1992b; 66: 4536–4539
   Google Scholar
• Merrill J E, Chen I S Y. HIV‐1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J 1991; 5: 2391–2397
   PubMed Web of Science ®Google Scholar
• Meyaard L, Otto S A, Jonker R R, Mijnster M K, Keet R P M, Miedema F. Progammed death of T cells in HIV‐1 infection. Science 1992; 257: 217–219
   PubMed Web of Science ®Google Scholar
• Nath A, Psooy K, Martin C, Knudsen B, Magnuson D S K, Haughey N, Geiger J D. Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J Virol 1996; 70: 1475–1480
   PubMed Web of Science ®Google Scholar
• Navia B A, Jordan B D, Price R W. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986; 19: 517–524
   PubMed Web of Science ®Google Scholar
• Petito C K, Roberts B. Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol 1995; 146: 1121–1130
   PubMed Web of Science ®Google Scholar
• Philippon V, Vellutini C, Gambarelli D, Harkiss G, Arbuthnott G, Metzger D, Roubin R, Filippi P. The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: Involvement of cytokines. Virology 1994; 205: 519–529
   PubMed Web of Science ®Google Scholar
• Purvis S F, Jacobberger J W, Sramkoski R M, Patki A H, Lederman M M. HIV type 1 Tat protein induces apoptosis and death in jurkat cells. AIDS Res Hum Retro 1995; 11: 443–450
   PubMed Web of Science ®Google Scholar
• Sharer L R. Pathology of HIV‐1 infection of the central nervous system (Review). J. Neuropath, and Exp Neurol 1992; 51: 3–11
   PubMed Web of Science ®Google Scholar
• Sodroski J, Rosen C, Wong‐Staal F, Salahuddin S Z, Popovic M, Arya S, Gallo R C, Haseltine W A. Trans‐acting transcriptional regulation of human T‐cell leukemia virus type III long terminal repeat. Science 1985; 227: 171–173
   PubMed Web of Science ®Google Scholar
• Takahashi K, Wesselingh S L, Griffin D E, McArthur J C, Johnson R T, Glass J D. Localization of HIV‐1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol 1966; 39: 705–711
   Google Scholar
• Talley A, Dewhurst S, Perry S, Dollard S, Gummuluru S, Fine S, New D, Epstein L, Gendelman H, Gelbard H. Tumor Necrosis Factor Alpha‐Induced Apoptosis in Human Neuronal Cells: Protection by the Antioxidant N.‐Acetylcysteine and the Genes bcl‐2 and crm A. Mol Cell Biol 1995; 15: 2359–2366
   Google Scholar
• Vogel J, Hinrichs S H, Reynolds R K, Luciw P A, Jay G. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 1988; 335: 606–611
   PubMed Web of Science ®Google Scholar
• Walkins B A, Dorn H H, Kelly W B, Armstrong R C, Potts B J, Michael F, Kufta C V, Dubois‐Dalcq M. Specific tropism of HIV‐1 for microglial cells in primary human brain cultures. Science 1990; 249: 549–553
   Google Scholar
• Westendorp M O, Frank R, Ochsenbauer C, Strieker K, Dhein J, Walczak H, Debatin K ‐M, Krammer P H. Sentitization of T cells to CD95‐mediated apoptosis by HIV‐1 Tat and gp120. Nature 1995a; 375: 497–500
   PubMed Web of Science ®Google Scholar
• Westendorp M O, Shatrov V A, Schulze‐Osthoff K, Frank R, Kraft M, Los M, Krammer P H, Droge W, Lehmann V. HIV‐1 Tat potentiates TNF‐induced NF‐kB activation and cytotoxicity by altering the cellular redox state. EMBO J 1995b; 14: 546–554
   PubMed Web of Science ®Google Scholar
• Wiley C A, Schrier R D, Nelson J A, Lampert P W, Oldstone M B A. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 1986; 83: 7089–7093
   PubMed Web of Science ®Google Scholar
• Wiley C A, Masliah E, Morey M, Lemere C, DeTeresa R, Grafe M, Hansen L, Terry R. Neocortical damage during HIV infection. Ann Neurol 1991; 29: 651–657
   PubMed Web of Science ®Google Scholar